Sökning: "pharmaceutical policy"
Visar resultat 11 - 15 av 22 avhandlingar innehållade orden pharmaceutical policy.
11. Konstitueringen av ett vetenskapligt objekt : Exemplet - det manliga klimakteriet
Sammanfattning : How are new scientific concepts of illnesses and disorder formed? The last fifty years have seen a dramatic increase in new diagnoses incorporated into medical manuals. The concept of the male menopause, or the andropause diagnosis, is suitable for studying how medical knowledge is produced, since it has alternated between being and not being part of the acknowledged medical knowledge since the beginning of the 19th century, when it was originally launched. LÄS MER
12. Drug utilization studies as support to decisions in drug policy in Estonia
Sammanfattning : The main purpose of the present studies was to describe the use of drugs in Estonia in an international perspective and to study factors determining changes in drug utilization. An important aim of evaluating drug utilization in Estonia was to use the data as a management instrument in areas where initiatives should be taken towards improved use of drugs. LÄS MER
13. Parallel Trade, Reference Pricing and Competition in the Pharmaceutical Market: Theory and Evidence
Sammanfattning : Paper I. Reference Pricing: Making Parallel Trade in Pharmaceuticals Work This paper shows that parallel trade makes pharmaceutical manufacturers reduce their prices in the home (importing) country more when it is combined with the healthcare reimbursement policy of reference pricing, requiring consumers to pay the full extra cost if they don’t buy cheaper parallel imported drugs. LÄS MER
14. Price sensitivity and regional variation in health care
Sammanfattning : Understanding the consequences of current health policy is important in order to design and develop a health care system suitable for future challenges. The purpose of this thesis is to bring evidence on the determinants of regional variation in health care and on individuals’ responsiveness to patient out-of-pocket prices in Sweden. LÄS MER
15. The value of evaluating and implementing pharmaceuticals
Sammanfattning : Pharmaceuticals are a central part of high-quality health care and a resource for improving population health. However, high prices set by private companies who develop and own the rights to new pharmaceuticals question the value that they contribute to the health care system. LÄS MER